The marginal benefits of healthcare spending in the Netherlands:Estimating cost‐effectiveness thresholds using a translog production function

New technologies may displace existing, higher‐value care under a fixed bud-get. Countries aim to curtail adoption of low‐value technologies, for example,by installing cost‐effectiveness thresholds. Our objective is to estimate theopportunity cost of hospital care to identify a threshold value for the Nether-lands. To this aim, we combine claims data, mortality data and quality of lifequestionnaires from 2012 to 2014 for 11,000 patient groups to obtain quality‐adjusted life‐year (QALY) outcomes and spending. Using a fixed effectstranslog model, we estimate that a 1% increase in hospital spendi... Mehr ...

Verfasser: Stadhouders, Niek
Koolman, Xander
van Dijk, Christel E
Jeurissen, Patrick
Adang, Eddy
Dokumenttyp: Artikel
Erscheinungsdatum: 2019
Reihe/Periodikum: Stadhouders , N , Koolman , X , van Dijk , C E , Jeurissen , P & Adang , E 2019 , ' The marginal benefits of healthcare spending in the Netherlands : Estimating cost‐effectiveness thresholds using a translog production function ' , Health Economics , vol. 28 , no. 11 , pp. 1331-1344 . https://doi.org/10.1002/hec.3946
Schlagwörter: cost-effectiveness / health care spending / QALY / threshold / translog function / /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being / name=SDG 3 - Good Health and Well-being
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26843240
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://research.vu.nl/en/publications/11649d0e-0f2d-460a-865c-04d4474cf226

New technologies may displace existing, higher‐value care under a fixed bud-get. Countries aim to curtail adoption of low‐value technologies, for example,by installing cost‐effectiveness thresholds. Our objective is to estimate theopportunity cost of hospital care to identify a threshold value for the Nether-lands. To this aim, we combine claims data, mortality data and quality of lifequestionnaires from 2012 to 2014 for 11,000 patient groups to obtain quality‐adjusted life‐year (QALY) outcomes and spending. Using a fixed effectstranslog model, we estimate that a 1% increase in hospital spending on averageincreases QALY outcomes by 0.2%. This implies a threshold of€73,600 perQALY, with 95% confidence intervals ranging from€53,000 to€94,000 perQALY. The results stipulate that new technologies with incremental cost effec-tiveness ratios exceeding the Dutch upper reference value of€80,000 mayindeed displace more valuable care.